Brief: Hologic Q3 Adjusted EBITDA USD 338.5 Million Vs. IBES Estimate USD 333.4 Million
29/07/2024 21:01
Jul 29 (Reuters) - Hologic Q3 adjusted net income USD 250.7 million vs. IBES estimate USD 240.7 million. * Q3 net income USD 194.5 million * Q3 operating margin 24.1% * Q3 adjusted operating margin 31.2% * Q3 adjusted gross margin 61.1% * Q3 gross margin 55.4% * Q3 revenue USD 1,011.4 million vs. IBES estimate USD 1,000 million * outlook FY EPS USD 3.37-3.44 * outlook FY adjusted EPS USD 4.04-4.11
Recent news on Hologic
See all newsBrief: Blackstone And Tpg Complete Acquisition Of Hologic
Casey's General Stores edges higher ahead of replacing Hologic in S&P 500
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: S&P Dow Jones Indices Says Casey's General Stores Inc. Will Replace Hologic Inc. In The S&P 500 Effective Prior To The Market Open On April 9